# Sororin locks the DNA-exit gate of cohesin to preserve sister-chromatid cohesion

**Authors:** Qinfu Chen, Xueying Yuan, Miao Shi, Xinyu Zhou, Shukai Zhu, Weiguo Lu, Haiyan Yan, Fangwei Wang

PMC · DOI: 10.1038/s41467-026-70484-2 · 2026-03-10

## TL;DR

This paper reveals that Sororin directly locks a DNA-exit gate in the cohesin complex to maintain sister-chromatid cohesion, in addition to its known role in regulating Wapl-Pds5 interactions.

## Contribution

The study identifies a novel structural role of Sororin's C-terminal region in directly stabilizing cohesin's DNA-exit gate.

## Key findings

- Sororin's C-terminal region locks the RAD21-SMC3 interface to preserve sister-chromatid cohesion.
- Disruption of Sororin's gate engagement abolishes cohesion in a Wapl-dependent manner.
- Mitotic phosphorylation of Sororin selectively disrupts Pds5 binding but preserves gate engagement.

## Abstract

The cohesin complex mediates sister-chromatid cohesion by topologically entrapping DNA within an SMC1-SMC3-RAD21 ring, yet how Sororin preserves cohesion beyond its known role of antagonizing Pds5 binding to the release factor Wapl has remained unclear. Here, we show that the extreme C-terminal region (CTR) of Sororin functions as a direct structural lock for cohesin’s DNA-exit gate by engaging the RAD21-SMC3 interface. Centromere-tethered Sororin-CTR fully restores cohesion after Sororin depletion, whereas constitutive chromatin tethering prevents cohesin removal, recapitulating Wapl-loss phenotypes, including impaired mitotic chromosome condensation, decatenation and segregation. Through biochemical reconstitution, AlphaFold3-guided modeling, and targeted mutagenesis, we define conserved hydrophobic and electrostatic contacts between Sororin-CTR and the RAD21-SMC3 gate, the disruption of which abolishes cohesion in a Wapl-dependent manner. Furthermore, mitotic phosphorylation of Sororin selectively disrupts Pds5 binding while leaving gate engagement intact, providing a regulated molecular switch for cohesin release. Together, these findings redefine Sororin as a dual-function regulator that both antagonizes Wapl-Pds5 and directly locks the RAD21-SMC3 exit gate to stabilize sister-chromatid cohesion while permitting its timely dissolution.

Chen et al. identify that the extreme C-terminal region of Sororin directly locks the cohesin DNA-exit gate to stabilize sister-chromatid cohesion, a mechanism distinct from its established role in antagonizing Wapl binding to Pds5.

## Linked entities

- **Genes:** CDCA5 (cell division cycle associated 5) [NCBI Gene 113130], pds5 (precocious dissociation of sisters 5) [NCBI Gene 36286], WAPL (WAPL cohesin release factor) [NCBI Gene 23063], RAD21 (RAD21 cohesin complex component) [NCBI Gene 5885], SMC1A (structural maintenance of chromosomes 1A) [NCBI Gene 8243], SMC3 (structural maintenance of chromosomes 3) [NCBI Gene 9126]
- **Proteins:** vtd (verthandi)

## Full-text entities

- **Genes:** cdca5 (cell division cycle associated 5) [NCBI Gene 559398] {aka fb18a08, si:dkey-273o13.2, wu:fb18a08, wu:fd13f03}, CENPC (centromere protein C) [NCBI Gene 1060] {aka CENP-C, CENPC1, MIF2, hcp-4}, CHKA (choline kinase alpha) [NCBI Gene 1119] {aka CHK, CK, CKI, EK, NEDMIMS}, MBP (myelin basic protein) [NCBI Gene 4155], INCENP (inner centromere protein) [NCBI Gene 3619], smc3 (structural maintenance of chromosomes 3) [NCBI Gene 324475] {aka cspg6, im:7142991, wu:fb22e01, wu:fc30d07}, CDK1 (cyclin dependent kinase 1) [NCBI Gene 983] {aka CDC2, CDC28A, P34CDC2}, CDCA5 (cell division cycle associated 5) [NCBI Gene 113130] {aka SORORIN}, CALCR (calcitonin receptor) [NCBI Gene 799] {aka CRT, CT-R, CTR, CTR1}, PLK1 (polo like kinase 1) [NCBI Gene 5347] {aka PLK, STPK13}, rad21a (RAD21 cohesin complex component a) [NCBI Gene 322275] {aka rad21, wu:fb55d02, wu:fb93f04}, calcr (calcitonin receptor) [NCBI Gene 560268] {aka si:ch211-77k19.2}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, WAPL (WAPL cohesin release factor) [NCBI Gene 23063] {aka FOE, KIAA0261, WAPAL}, SMC1A (structural maintenance of chromosomes 1A) [NCBI Gene 8243] {aka CDLS2, DEE85, DXS423E, EIEE85, SB1.8, SMC1}, PDS5B (PDS5 cohesin associated factor B) [NCBI Gene 23047] {aka APRIN, AS3, CG008}, CENPB (centromere protein B) [NCBI Gene 1059], SGO1 (shugoshin 1) [NCBI Gene 151648] {aka CAID, NY-BR-85, SGO, SGOL1}, ESCO2 (establishment of sister chromatid cohesion N-acetyltransferase 2) [NCBI Gene 157570] {aka 2410004I17Rik, EFO2, EFO2p, JHS, RBS, hEFO2}, H2BC21 (H2B clustered histone 21) [NCBI Gene 8349] {aka GL105, H2B, H2B-GL105, H2B.1, H2BE, H2BFQ}, STAG2 (STAG2 cohesin complex component) [NCBI Gene 10735] {aka HPE13, MKMS, NEDXCF, SA-2, SA2, SCC3B}, ERCC6L (ERCC excision repair 6 like, spindle assembly checkpoint helicase) [NCBI Gene 54821] {aka PICH, RAD26L}, STAG1 (STAG1 cohesin complex component) [NCBI Gene 10274] {aka MRD47, SA1, SCC3A}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, PDS5A (PDS5 cohesin associated factor A) [NCBI Gene 23244] {aka PIG54, SCC-112, SCC112}, ESPL1 (extra spindle pole bodies like 1, separase) [NCBI Gene 9700] {aka ESP1, SEPA}, AURKB (aurora kinase B) [NCBI Gene 9212] {aka AIK2, AIM-1, AIM1, ARK-2, ARK2, AurB}, CST12P (cystatin 12, pseudogene) [NCBI Gene 106478911] {aka Cst, Ctes4, E2}, TUBA1B (tubulin alpha 1b) [NCBI Gene 10376] {aka K-ALPHA-1}, PTPA (protein phosphatase 2 phosphatase activator) [NCBI Gene 5524] {aka PARK25, PP2A, PPP2R4, PR53}, DYM (dymeclin) [NCBI Gene 54808] {aka DMC, SMC}, SMC3 (structural maintenance of chromosomes 3) [NCBI Gene 9126] {aka BAM, BMH, CDLS3, CSPG6, HCAP, SMC3L1}, RAD21 (RAD21 cohesin complex component) [NCBI Gene 5885] {aka CDLS4, HR21, HRAD21, MCD1, MGS, NXP1}, DNAH8 (dynein axonemal heavy chain 8) [NCBI Gene 1769] {aka ATPase, SPGF46, hdhc9}, ESCO1 (establishment of sister chromatid cohesion N-acetyltransferase 1) [NCBI Gene 114799] {aka A930014I12Rik, CTF, ECO1, EFO1, ESO1}
- **Diseases:** tumorigenesis (MESH:D063646), cancer (MESH:D009369), developmental disorders (MESH:D002658)
- **Chemicals:** MG132 (MESH:C072553), FuGENE 6 (MESH:C411955), NaF (MESH:D012969), TRIzol (MESH:C411644), Hesperadin (MESH:C474723), water (MESH:D014867), ethanol (MESH:D000431), BI 2536 (MESH:C518477), biotin (MESH:D001710), DTT (MESH:D004229), SDS (MESH:D012967), isopropanol (MESH:D019840), FA (MESH:C030544), blasticidin (MESH:C004500), DEPC (MESH:D004047), MgCl2 (MESH:D015636), Dox (MESH:D004318), NaCl (MESH:D012965), acetonitrile (MESH:C032159), Triton X-100 (MESH:D017830), CBB (MESH:C004692), streptomycin (MESH:D013307), C (MESH:D002244), NP-40 (MESH:C010615), Ni (MESH:D009532), EDTA (MESH:D004492), F12 (MESH:C007782), polybrene (MESH:D006583), chloroform (MESH:D002725), PFA (MESH:C003043), phosphoserine (MESH:D010768), ATP (MESH:D000255), CO2 (MESH:D002245), EGTA (MESH:D004533), glutathione (MESH:D005978), Roscovitine (MESH:D000077546), SFB (MESH:C069226), DAPI (MESH:C007293), DMSO (MESH:D004121), Cy5 (MESH:C085321), KCl (MESH:D011189), Lys (MESH:D008239), okadaic acid (MESH:D019319), G418 (MESH:C010680), BI (MESH:D001729), Oligofectamine (MESH:C484027), puromycin (MESH:D011691), glycerol (MESH:D005990), penicillin (MESH:D010406), Alexa Fluor 647 (MESH:C569686), RO-3306 (MESH:C512984), HEPES (MESH:D006531), Cy3 (-), desthiobiotin (MESH:C004749), maltose (MESH:D008320), thymidine (MESH:D013936), oil (MESH:D009821), nocodazole (MESH:D015739), Alexa Fluor 488 (MESH:C000711379), phenylmethylsulfonyl fluoride (MESH:D010664)
- **Species:** Sus scrofa (pig, species) [taxon 9823], Mus musculus (house mouse, species) [taxon 10090], Lentivirus (genus) [taxon 11646], Cavia porcellus (domestic guinea pig, species) [taxon 10141], Danio rerio (leopard danio, species) [taxon 7955], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** K105A, S145E, K50E, K105, F241, K105Q, F241A, W233A, K106A, E252K, K106Q, D793K, F247, K1034, R1099E, K1034E, R1099, K106, S145N, F247A, K1038
- **Cell lines:** FuGENE 6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985), 8H-J — Homo sapiens (Human), Transformed cell line (CVCL_2491), Lenti — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_A4EW), 293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), E. coli BL21 (DE3) — Mus musculus (Mouse), Hybridoma (CVCL_B7HM), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), RPE-1 — Homo sapiens (Human), Telomerase immortalized cell line (CVCL_4388), Y3A — Mus musculus (Mouse), Hybridoma (CVCL_E990), HEK — Homo sapiens (Human), Transformed cell line (CVCL_0045)

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12976308/full.md

---
Source: https://tomesphere.com/paper/PMC12976308